Q4 2019 13F Holders as of 12/31/2019
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
105M
-
Number of holders
-
684
-
Total 13F shares, excl. options
-
73.7M
-
Shares change
-
+289K
-
Total reported value, excl. options
-
$27.7B
-
Value change
-
+$215M
-
Put/Call ratio
-
1.17
-
Number of buys
-
298
-
Number of sells
-
-287
-
Price
-
$375.48
Significant Holders of REGENERON PHARMACEUTICALS, INC. - COMMON STOCK (REGN) as of Q4 2019
783 filings reported holding REGN - REGENERON PHARMACEUTICALS, INC. - COMMON STOCK as of Q4 2019.
REGENERON PHARMACEUTICALS, INC. - COMMON STOCK (REGN) has 684 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 73.7M shares
of 105M outstanding shares and own 70.23% of the company stock.
Largest 10 shareholders include Capital World Investors (8.33M shares), VANGUARD GROUP INC (6.25M shares), BlackRock Inc. (6.14M shares), HARRIS ASSOCIATES L P (4.37M shares), LOOMIS SAYLES & CO L P (3.69M shares), STATE STREET CORP (3.57M shares), FMR LLC (3.23M shares), WELLINGTON MANAGEMENT GROUP LLP (2.25M shares), ALLIANCEBERNSTEIN L.P. (1.95M shares), and POLEN CAPITAL MANAGEMENT LLC (1.68M shares).
This table shows the top 684 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.